Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal

Gabriella Bergamini1, Maria Elisa Perico2, Stefano Di Palma3

  • 1Translational Microbiology, Antibacterial Discovery, Aptuit (Verona) S.r.l., an Evotec Company DD&D Research Centre, Verona, Italy.

Plos One
|December 2, 2021
PubMed

Insights

This study compared methods for inducing pneumonia in mice using multidrug-resistant Acinetobacter baumannii. Oropharyngeal aspiration and intratracheal instillation effectively created consistent lung infections, unlike intranasal inoculation.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Multidrug-resistant (MDR) Acinetobacter baumannii causes severe healthcare-associated pneumonia.
  • Existing mouse models often yield self-limiting infections, limiting research on MDR A. baumannii pneumonia.
  • Standard inoculation methods like intranasal and intratracheal instillation have limitations in reproducibility.

Purpose of the Study:

  • To compare the efficacy of oropharyngeal aspiration, intranasal inoculation, and intratracheal instillation in inducing consistent lung infections with MDR A. baumannii in immunocompromised mice.
  • To characterize pneumonia induced by intratracheal and oropharyngeal methods, including histopathology, inflammation biomarkers, and leukocyte infiltration.
  • To evaluate the therapeutic effect of tigecycline on bacterial load and inflammation.

Main Methods:

  • Comparison of three inoculation techniques (intranasal, intratracheal, oropharyngeal) for inducing pneumonia in immunocompromised mice using two MDR A. baumannii clinical isolates.
  • Histopathological analysis of lung lesions and measurement of inflammatory biomarkers (cytokines) in infected mice.
  • Assessment of tigecycline efficacy on bacterial load and inflammatory markers.

Main Results:

  • Intranasal inoculation failed to establish significant lung colonization by MDR A. baumannii.
  • Both intratracheal instillation and oropharyngeal aspiration successfully induced robust lung infections with reduced variability.
  • Tigecycline treatment effectively reduced bacterial load and cytokine levels in the lungs.
  • Histopathological findings correlated with biomarker analysis, confirming lesion severity and inflammatory response.

Conclusions:

  • Intratracheal instillation and oropharyngeal aspiration are suitable methods for establishing consistent MDR A. baumannii pneumonia in mouse models.
  • Oropharyngeal aspiration is a safer, easier, and faster alternative to intratracheal instillation, requiring less specialized equipment and technical skill.
  • These findings provide a reliable preclinical model for studying MDR A. baumannii pneumonia and evaluating novel therapeutics.

Related Concept Videos